Add like
Add dislike
Add to saved papers

Consequences of Clot Formation and Hyphema Post-internal Trabeculotomy for Glaucoma.

PRECIS: Clot formation and hyphema following internal trabeculotomy represent distinct clinical entities. The eyes with clot formation exhibited a more pronounced postsurgical intraocular pressure spike, longer residual intracameral bleeding, and a higher risk of reoperation.

PURPOSE: To investigate the consequences of clot formation and hyphema in the anterior chamber after internal trabeculotomy.

METHODS: In this retrospective interventional comparative study, we investigated the surgical outcomes of internal trabeculotomy in 142 eyes of 142 patients at Sensho-kai Eye Institute.

RESULTS: Concurrent clot formation and L≥2 hyphema (height of hyphema ≥1 mm) was observed in 22 eyes. In these cases, the post-surgical IOP was 29.3 mmHg at 1 week, significantly higher than the 16.1 mmHg in eyes that had L≥2 hyphema but without clot formation (P=0.0002). However, the 1-week post-surgical IOP in L≥2 hyphema and clot (-) eyes, which measured 16.1 mmHg was not significantly greater than that in L<2 hyphema and clot (-) eyes, which measured 18.7 mmHg (P=0.162). Thus, clot formation was identified as a significant factor contributing to high postsurgical IOP at 1 week. The resolution time for anterior chamber bleeding in eyes with concurrent clot formation and L≥2 hyphema was 12.3 days, longer than the 5.8 days observed in L≥2 hyphema eyes without clot formation (P=0.016). Among the 22 eyes with concurrent L≥2 hyphema and clot formation, eight required anterior chamber washout. Three of the ten eyes that underwent washout necessitated additional trabeculectomy, a rate significantly higher than that in non-washout eyes (P<0.001).

CONCLUSION: After internal trabeculotomy, the sequelae of concurrent clot formation and L≥2 hyphema in the anterior chamber were more severe than those of simple hyphema without clots. Clot formation negatively affected post-operative IOP.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app